Примери за използване на Other proton pump inhibitors на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Omeprazole and other proton pump inhibitors.
Other proton pump inhibitors(saquinavir/ritonavir 1000/100 mg bid).
You are allergic to medicines containing other proton pump inhibitors.
Other proton pump inhibitors(saquinavir/ ritonavir 1000/ 100 mg bid) Others. .
Although not studied,similar results are expected with other proton pump inhibitors.
Omeprazole like other proton pump inhibitors must not be used concomitantly with nelfinavir(see section 4.5).
If you are allergic to medicines containing other proton pump inhibitors e.g. pantoprazole.
The metabolism of other proton pump inhibitors which are CYP2C19 substrates may also be inhibited by voriconazole.
Nilotinib may be used concurrently with esomeprazole or other proton pump inhibitors as needed.
Omeprazole like other proton pump inhibitors(PPIs) should not be used concomitantly with nelfinavir(see section 4.5).
If you are allergic to medicines containing other proton pump inhibitors.
Pantoprazole and other proton- pump inhibitors were co-administered with Pradaxa in clinical trials and no effects on bleeding or efficacy were observed.
Caution is recommended when nelfinavir is co-administered with other proton pump inhibitors.
If omeprazole or other proton pump inhibitors are taken concomitantly with Invirase/ ritonavir, monitoring for potential saquinavir toxicities is recommended.
No data are available on the concomitant administration of Invirase/ ritonavir and other proton pump inhibitors.
Other proton pump inhibitors that are CYP2C19 substrates may also be inhibited by voriconazole and may result in increased plasma concentrations of these medicinal products.
Some medicines that treat diseases related to the acid in the stomach- such as omeprazole or other proton pump inhibitors.
Use of proton pump inhibitors or other acid-reducing medications.
Co-administration of proton pump inhibitors or other antiulcer medicinal products may increase plasma levels of raltegravir.
Other medicines, called proton pump inhibitors, such as Prilosec and Prevacid, are another option.
For eradication of Helicobacter pylori Klacid is prescribed 500 mg 2 times a day in combination with proton pump inhibitors and other antimicrobial drugs.
Therefore, no dose adjustments are required when Alecensa is co-administered with proton pump inhibitors or other medicinal products which raise gastric pH(e.g. H2 receptor antagonists or antacids).
H2-receptor antagonists and proton pump inhibitors, see“Studies conducted with other medicinal products”.
It is also noted that there are other well-established agents available for this indication, including proton pump inhibitors and H2 receptor antagonists, for which a positive benefit-risk balance has been clearly demonstrated for acute and chronic use.
Population PK analysis indicates that co-administration of acid-reducing agents including proton pump inhibitors and histamine receptor 2 antagonists(H2RA), or other acid-reducing agents had no significant impact on the absorption of talazoparib.
Do not take this medicine with other medicines that limit the amount of acid produced in your stomach such as proton pump inhibitors(e.g. pantoprazole, lansoprazole, rabeprazole or omeprazole) or an H2 antagonist(e.g. ranitidine or famotidine).
The effect of other H2 receptor antagonists(e.g. famotidine, ranitidine) and proton pump inhibitors(e.g. omeprazole) that may suppress gastric acidity for several hours on plasma levels of posaconazole has not been studied but a reduction in bioavailability may occur so that coadministration should be avoided if possible.
As with other NSAIDs, the use of piroxicam in combination with protective agents(e.g. misoprostol or proton pump inhibitors) must be considered for these atrisk patients.
Proton pump inhibitors lead to a faster relief of the symptoms and healing of ulcer, as compared with the two other groups of medicaments.
Combination therapy with protective agents(e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose acetylsalicylic acid or other drugs likely to increase gastrointestinal risk(see below and section 4.5).